Chan L - Search Results

1

Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Chen W, Xie A, Chan L. Chen W, et al. Among authors: chan l. Transl Res. 2013 Apr;161(4):217-29. doi: 10.1016/j.trsl.2012.12.017. Epub 2013 Jan 22. Transl Res. 2013. PMID: 23348026 Free PMC article. Review.

2

PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.

Li R, Lee J, Kim MS, Liu V, Moulik M, Li H, Yi Q, Xie A, Chen W, Yang L, Li Y, Tsai TH, Oka K, Chan L, Yechoor V. Li R, et al. Among authors: chan l. Diabetes. 2015 Feb;64(2):529-40. doi: 10.2337/db13-1737. Epub 2014 Oct 20. Diabetes. 2015. PMID: 25332429 Free PMC article.

3

Anti-TCRβ mAb in Combination With Neurogenin3 Gene Therapy Reverses Established Overt Type 1 Diabetes in Female NOD Mice.

Xie A, Li R, Jiang T, Yan H, Zhang H, Yang Y, Yang L, Yechoor V, Chan L, Chen W. Xie A, et al. Among authors: chan l. Endocrinology. 2017 Oct 1;158(10):3140-3151. doi: 10.1210/en.2016-1947. Endocrinology. 2017. PMID: 28977608 Free PMC article.

4

Stem cell approaches for the treatment of type 1 diabetes mellitus.

Wagner RT, Lewis J, Cooney A, Chan L. Wagner RT, et al. Among authors: chan l. Transl Res. 2010 Sep;156(3):169-79. doi: 10.1016/j.trsl.2010.06.005. Epub 2010 Jul 9. Transl Res. 2010. PMID: 20801414 Free PMC article. Review.

5

Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic mice.

Buras ED, Yang L, Saha P, Kim J, Mehta P, Yang Y, Hilsenbeck S, Kojima H, Chen W, Smith CW, Chan L. Buras ED, et al. Among authors: chan l. FASEB J. 2015 Aug;29(8):3537-48. doi: 10.1096/fj.15-271452. Epub 2015 May 7. FASEB J. 2015. PMID: 25953849 Free PMC article.

6

The Krüppel-like zinc finger protein GLIS3 transactivates neurogenin 3 for proper fetal pancreatic islet differentiation in mice.

Yang Y, Chang BH, Yechoor V, Chen W, Li L, Tsai MJ, Chan L. Yang Y, et al. Among authors: chan l. Diabetologia. 2011 Oct;54(10):2595-605. doi: 10.1007/s00125-011-2255-9. Epub 2011 Jul 23. Diabetologia. 2011. PMID: 21786021 Free PMC article.

7

In vivo gene therapy for diabetes mellitus.

Chan L, Fujimiya M, Kojima H. Chan L, et al. Trends Mol Med. 2003 Oct;9(10):430-5. doi: 10.1016/j.molmed.2003.08.003. Trends Mol Med. 2003. PMID: 14557055 Review.

8

Erratum. PD-L1-Driven Tolerance Protects Neurogenin3-Induced Islet Neogenesis to Reverse Established Type 1 Diabetes in NOD Mice. Diabetes 2015;64:529-540.

Li R, Lee J, Kim MS, Liu V, Moulik M, Li H, Yi Q, Xie A, Chen W, Yang L, Li Y, Tsai TH, Oka K, Chan L, Yechoor V. Li R, et al. Among authors: chan l. Diabetes. 2015 Jul;64(7):2685. doi: 10.2337/db15-er07. Diabetes. 2015. PMID: 26106199 Free PMC article. No abstract available.

9

Gene therapy progress and prospects: gene therapy for diabetes mellitus.

Yechoor V, Chan L. Yechoor V, et al. Among authors: chan l. Gene Ther. 2005 Jan;12(2):101-7. doi: 10.1038/sj.gt.3302412. Gene Ther. 2005. PMID: 15496957 Review.

10

Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice.

Li R, Buras E, Lee J, Liu R, Liu V, Espiritu C, Ozer K, Thompson B, Nally L, Yuan G, Oka K, Chang B, Samson S, Yechoor V, Chan L. Li R, et al. Among authors: chan l. Gene Ther. 2015 Nov;22(11):876-82. doi: 10.1038/gt.2015.62. Epub 2015 Jul 14. Gene Ther. 2015. PMID: 26172077 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,138 results

Search Page

Filters